Drug Shortage Report for LEUCOVORIN CALCIUM INJECTION

Last updated on 2019-08-21 History
Report ID 86601
Drug Identification Number 02087316
Brand name LEUCOVORIN CALCIUM INJECTION
Common or Proper name LEUCOVORIN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) LEUCOVORIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 50ML
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-07-15
Actual start date 2019-06-27
Estimated end date 2019-10-30
Actual end date 2019-08-20
Shortage status Resolved
Updated date 2019-08-21
Company comments Inventory released August 9th and allocating 80% of total market demand.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-08-21 English Compare
v15 2019-08-20 French Compare
v14 2019-08-20 English Compare
v13 2019-08-13 French Compare
v12 2019-08-13 English Compare
v11 2019-08-06 French Compare
v10 2019-08-06 English Compare
v9 2019-07-03 French Compare
v8 2019-07-03 English Compare
v7 2019-06-28 French Compare
v6 2019-06-28 English Compare
v5 2019-06-28 English Compare
v4 2019-06-27 French Compare
v3 2019-06-27 English Compare
v2 2019-06-13 French Compare
v1 2019-06-13 English Compare